FierceBiotech Jan 28, 2026 Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech Jan 28, 2026 Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition: report
FierceBiotech Jan 28, 2026 CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'
FierceBiotech Jan 28, 2026 FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
FierceBiotech Jan 28, 2026 'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
Endpoints News Jan 28, 2026 FDA suspends Regenxbio gene therapy trials after patient developed brain tumor
Endpoints News Jan 28, 2026 HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
Lonza News Jan 28, 2026 Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
PLoS Biology Jan 28, 2026 Correction: Oxygen supersaturation has negligible effects on warming tolerance across diverse aquatic ectotherms
Illumina Jan 28, 2026 Agilus Diagnostics installs Illumina NovaSeq X to revolutionise genomic testing in India - BioSpectrum India